Improving hand function after spinal cord injury using electrical stimulation
Official title: Spinal Cord Associative Plasticity Study
Run by Columbia University · NCT05163639 · Data updated 2026-11-12
This study is testing if a new way of using electrical stimulation on the brain and spinal cord can help people with cervical spinal cord injuries regain better control and movement in their arms and hands.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 92 (estimated) |
| Sponsor | Columbia University Academic / other |
| Locations | 3 sites (New York, New York and 2 other locations) |
| Status | Recruiting |
| Started | September 10, 2021 |
| Main results expected | December 30, 2027 |
| Study ends | December 30, 2027 |
| Registry record updated | June 18, 2026 |
| Trial ID | NCT05163639 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18-80 with cervical spinal cord injuries who have some residual muscle function in their hands.
✕Probably not a fit
Patients with extensive neurological diseases or those who are ventilator-dependent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates spinal cord associative plasticity (SCAP), a technique that combines cortical and spinal electrical stimulation to enhance recovery of arm and hand function in individuals with cervical spinal cord injuries. The research aims to determine if electrical stimulation can strengthen signaling through the spinal cord to the muscles and improve understanding of spinal cord function. Participants will undergo both non-invasive and intraoperative stimulation to assess the effects of paired brain and spinal cord stimulation on muscle activation and movement recovery. The study seeks to translate promising animal research into human therapy for those with paralysis or weakness following spinal cord injury.
Why it matters
Potential benefit: If successful, this approach could lead to new therapies that significantly improve hand and arm function in patients with spinal cord injuries.
How similar studies have gone: Previous studies in animal models have shown success with similar stimulation techniques, but this approach is novel in human subjects.
Who can join: the full rules
Show full inclusion / exclusion criteria
NON-INVASIVE Inclusion Criteria: (All participants) * Age between 18-80 years. * Must have stable prescription medication for 30 days prior to screening * Must be able to: abstain from alcohol, smoking and caffeine consumption on the day of each experiment; abstain from recreational drugs for the entirety of the study; commit to study requirements (i.e., 7 visits); provide informed consent. (Able-bodied participants) * No known central or peripheral neurological disease or injury. (SCI participants - including patients scheduled for intraoperative procedures) * Score of 1-4 (out of 5) on manual muscle testing of finger extension, finger flexion, or finger abduction in left or right hand. Exclusion criteria: (All participants) * Personal or extensive family history of seizures; * Ventilator dependence or patent tracheostomy site; * Use of medications that significantly lower seizure threshold, such as amphetamines, neuroleptics, dalfampridine, and bupropion; * History of stroke, brain tumor, brain abscess, or multiple sclerosis; * History of moderate or severe head trauma (loss of consciousness for greater than one hour or evidence of brain contusion or hemorrhage or depressed skull fracture on prior imaging); * History of implanted brain/spine/nerve stimulators, aneurysm clips, ferromagnetic metallic implants in the head (except for inside mouth); cochlear implants; cardiac pacemaker/defibrillator; intracardiac lines; currently increased intracranial pressure; or other contraindications to brain or spine stimulation; * Significant coronary artery or cardiac conduction disease; recent history of myocardial infarction and heart failure with an ejection fraction of less than 30% or with a New York Heart Association Functional Classification of Class III or IV; * Recent history (within past 6 months) of recurrent autonomic dysreflexia, defined as a syndrome of sudden rise in systolic pressure greater than 20 mm Hg or diastolic pressure greater than 10 mm Hg, without rise in heart rate, accompanied by symptoms such as headache, facial flushing, sweating, nasal congestion, and blurry vision (this will be closely monitored during all screening and testing procedures); * History of significant hearing problems; * History of bipolar disorder; * History of suicide attempt; * Active psychosis; * Recent history (\>1 year) of chemical substance dependency or significant psychosocial disturbance; * Heavy alcohol consumption (greater than equivalent of 5oz of liquor) within previous 48 hours; * Open skin lesions over the face, neck, shoulders, or arms; * Pregnancy; and * Unsuitable for study participation as determined by study physician. INTRA-OPERATIVE Inclusion Criteria: * Clinical indication for cervical spine surgery. Exclusion criteria: (For experiments involving cortical stimulation) * Epilepsy; * A history of skull surgery with metal implants; * Cochlear implants; * Patients with aneurysm stents in neck or brain blood vessels; * Evidence of skull shrapnel; (For experiments involving spinal cord stimulation) * Stimulation devices in the neck or chest (e.g., vagal nerve stimulation, cardiac patients with pacemakers)
Where it's running
-
Bronx Veterans Medical Research Foundation, Inc
New York, New York, United States Recruiting -
Columbia University Irving Medical Center
New York, New York, United States Recruiting -
Weill Cornell Medicine
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Jason B Carmel, M.D., Ph.D. — Columbia University
- Study coordinator: Jason B Carmel, M.D., Ph.D.
- Email: jbc28@cumc.columbia.edu
- Phone: 917-301-1882
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cervical spinal cord stimulation for improving arm and hand function
This study is testing different ways of using spinal cord stimulation to see if it can help people with cervical spinal cord injuries improve their arm and hand function.
-
Connexus® Brain-Computer Interface to restore communication and device control
This study will try the Connexus brain-computer interface to help people with severe loss of voluntary movement (for example from ALS, cervical spinal cord injury, or stroke) communicate and control computers.
-
Robotic implantation of a precise brain‑computer interface to restore communication
This project tests whether a robotically implanted Neuralink N1 brain implant can help adults with severe, irreversible speech loss from ALS, spinal cord injury, or stroke communicate again.
-
Robotically implanted Neuralink N1 brain-computer interface to control external devices
This study will test whether a robotically implanted Neuralink N1 brain-computer interface can safely help people with high spinal cord injuries or ALS control computers and other external devices.
-
Robotically implanted brain chip to help control external devices
This tests a wireless, rechargeable brain implant (Neuralink N1) and a robot surgical system (R1) to help people with severe arm and hand paralysis control external devices.
-
Robotically implanted brain-computer interface for controlling devices
This study is testing a new brain implant and robot to see if they can help people with severe movement limitations control devices more easily.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.